Ubs Group Ag Opiant Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$9.38 - $20.29 $12,719 - $27,513
1,356 Added 93.78%
2,802 $56,000
Q3 2022

Nov 10, 2022
BUY
$9.52 - $13.48 $2,532 - $3,585
266 Added 22.54%
1,446 $16,000
Q2 2022

Aug 10, 2022
BUY
$10.12 - $23.32 $1,598 - $3,684
158 Added 15.46%
1,180 $14,000
Q1 2022

May 16, 2022
BUY
$19.54 - $33.59 $14,010 - $24,084
717 Added 235.08%
1,022 $22,000
Q4 2021

Feb 14, 2022
SELL
$22.51 - $36.79 $2,993 - $4,893
-133 Reduced 30.37%
305 $10,000
Q3 2021

Nov 15, 2021
SELL
$13.28 - $25.79 $10,052 - $19,523
-757 Reduced 63.35%
438 $11,000
Q2 2021

Aug 13, 2021
BUY
$10.5 - $14.19 $12,547 - $16,957
1,195 New
1,195 $16,000
Q1 2021

May 12, 2021
SELL
$8.2 - $14.49 $15,932 - $28,154
-1,943 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$6.87 - $8.88 $1,518 - $1,962
221 Added 12.83%
1,943 $16,000
Q3 2020

Nov 12, 2020
BUY
$7.48 - $9.54 $12,880 - $16,427
1,722 New
1,722 $13,000
Q1 2020

May 01, 2020
SELL
$9.11 - $14.42 $8,782 - $13,900
-964 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$13.16 - $15.96 $12,686 - $15,385
964 New
964 $14,000
Q2 2019

Aug 14, 2019
SELL
$10.25 - $13.98 $22,908 - $31,245
-2,235 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$13.02 - $15.94 $8,970 - $10,982
689 Added 44.57%
2,235 $30,000
Q4 2018

Feb 14, 2019
SELL
$13.84 - $18.79 $28,634 - $38,876
-2,069 Reduced 57.23%
1,546 $22,000
Q3 2018

Nov 14, 2018
BUY
$12.89 - $23.43 $21,023 - $38,214
1,631 Added 82.21%
3,615 $65,000
Q2 2018

Aug 14, 2018
SELL
$14.31 - $20.59 $27,417 - $39,450
-1,916 Reduced 49.13%
1,984 $28,000
Q1 2018

May 15, 2018
BUY
$18.8 - $26.5 $48,955 - $69,006
2,604 Added 200.93%
3,900 $75,000
Q4 2017

Feb 14, 2018
BUY
$18.16 - $40.15 $19,576 - $43,281
1,078 Added 494.5%
1,296 $29,000
Q3 2017

Nov 14, 2017
BUY
$15.23 - $50.5 $3,320 - $11,009
218
218 $8,000

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email